Two former FDA employees involved in the C-19 vaccine approval now work at Moderna.

Documents obtained under the Freedom of Information Act (FOIA) reveal how two former FDA employees involved in the COVID-19 vaccine approval now work at Moderna.

In part, the FDA recusal process aims to avoid potential conflicts of interest. However, some experts point out that this process has limitations and may not be enough.